Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

Similar documents
Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

Sedative-Hypnotics. Sedative Agents (General Considerations)

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)

Fundamentals of Pharmacology

Sedation For Cardiac Procedures A Review of

Benzodiazepines. Benzodiazepines

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

General Anesthesia. Mohamed A. Yaseen

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Sleep, oil on canvas, 1937, Salvador Dali.

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

Ms. Holly Golightly (Audrey Hepburn), Breakfast at Tiffany s, 1961

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

DRUGS THAT ACT IN THE CNS

Tranquilizers & Sedative-Hypnotics

General anesthesia. No single drug capable of achieving these effects both safely and effectively.

Pharmacological methods of behaviour management

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

May 2013 Anesthetics SLOs Page 1 of 5

Sedatives and Hypnotics. Ahmad Al-Tarifi. Zahra Khalil. Pharmacology. 1 P a g e

The Use of Midazolam to Modify Children s Behavior in the Dental Setting. by Fred S. Margolis, D.D.S.

Pharmacology of intravenous induction agents

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

BEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

POST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier

Core Safety Profile: Midazolam Route of Administration Tablets Procedure: FR/H/PSUR/0026/001 Decemebr 2011

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Buspirone Carbamazepine Diazepam Disulfiram Ethosuximide Flumazeil Gabapentin Lamotrigine

NEW ZEALAND DATASHEET

Anxiolytic and Hypnotic drugs

ANTIANXIETY DRUGS: BENZODIAZEPINES

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Core Safety Profile. Pharmaceutical form(s)/strength: Tablets 5 mg and 10 mg BE/H/PSUR/0002/002 Date of FAR:

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

P-RMS: FR/H/PSUR/0036/001

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg or 5 mg of diazepam.

PARACOD Tablets (Paracetamol + Codeine phosphate)

Variation in drug responses & Drug-Drug Interactions

General anesthetics. Dr. Shamil AL-Noaimy Lecturer of Pharmacology Dept. of Pharmacology College of Medicine

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

NEW ZEALAND DATA SHEET. HYPAM 0.125mg tablets are oval, flat, bevelled edged white tablets marked TZ on one side and scored on the other.

Novel Compounds for Treatment of Alcohol Addiction and Anxiety

ANNEX III LABELLING AND PACKAGE LEAFLET

PACKAGE LEAFLET: Information for the patient. DIAZEPAM Tablets 5 mg Solution for injection 10 mg / 2 ml (Diazepam)

SUMMARY OF PRODUCT CHARACTERISTICS

Induction Agents 2013/05/28 1

Sedative-Hypnotics & the Treatment of Hypersomnia October 22, 2018 Pharm 9002 Mark Beenhakker, Pharmacology

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Chapter 25. General Anesthetics

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

BACKGROUND Measuring renal function :

LOCAL AND GENERAL ANAESTHESIA. Semmelweis University Paedodontic and Orthodontic Clinic

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tube contains 5 mg diazepam in 2.5 ml or 10 mg diazepam in 2.5 ml solution.

LORAZEPAM. THERAPEUTICS Brands Ativan see index for additional brand names. Generic? Yes

Community Paediatric Policy for minimal sedation

Sedation in Children

I. Introduction Epilepsy is the tendency to have recurrent seizures unprovoked by systemic or acute neurologic insults. Antiepileptic drugs (AEDs)

SUMMARY OF PRODUCT CHARACTERISTICS. Zopiclone 7.5mg contains 7.5 mg of Zopiclone per tablet.

INTRAVENOUS DRUGS USED FOR THE

DEEP SEDATION TEST QUESTIONS

ALCOHOL Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl

Introducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building

Adverse drug reactions. Dr. Mark Haworth MBChB DA MRCA

Goals for sedation during mechanical ventilation

MR04A3 An isoindoline derivative, New Sedative/Anesthetic Agent

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

Chapter 15. Seizures. Learning Objectives. Learning Objectives 9/11/2012

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

EU Core Safety Profile

Procedural Sedation and Analgesia in the ED

Inhalation Sedation. Conscious Sedation. The IHS Technique. Historical Background WHY CONSCIOUS SEDATION? Learning outcomes:-

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

VI.2 Elements for a Public Summary

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

ULTIVA GlaxoSmithKline

INHALATION AGENTS 2013/05/28 1

General and Local Anesthetics TURNING POINT PHARM THURSDAY IMC606 Neuroscience Module

The Fifth Vital Sign.

Pain. Fear can keep the patient from going to the Drs at appropriate time

Stilnoct 10mg Tablets: White to off-white film-coated oblong tablet, scored and engraved SN 10 on one side, containing 10mg zolpidem tartrate.

improving the patient s quality of life.

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.

SANDOMIGRAN (pizotifen malate)

Drugs and the Brain. Sooren Moosavy and Vanessa Travieso

SUMMARY OF PRODUCT CHARACTERISTICS

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Principles of Pharmacology. Pharmacokinetics & Pharmacodynamics. Mr. D.Raju, M.pharm, Lecturer PHL-358-PHARMACOLOGY AND THERAPEUTICS-I

SUMMARY OF PRODUCT CHARACTERISTICS

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

Treatment of valium overdose

Transcription:

Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry Peter Walker Ideal Sedative Agent Anxiolysis Analgesic No effect on CVS No effect on respiratory system Not metabolised Easy and quick to change level of sedation Reversible No interactions with other drugs Long shelf life Cheap Benzodiazepines Discovered in 1955 Librium marketed in 1960 Diazepam discovered 1959 First used in anaesthesia 1966 1

Pharmacokinetics What the body does to the drug Half life metabolism Excretion Pharmacodynamics This is what the drug does to the body Sedation Analgesia Anxiolysis etc. Clinical Effects of Benzodiazepines Pharmacodynamically the same Differences Affinity for receptors (potency) Pharmacokinetic properties Half life Presence active metabolites 2

Benzodiazepines Actions Anxiolysis Anticonvulsion Slight Sedation reduced attention Amnesia Intense sedation Muscle relaxation Anaesthesia Increasing Dose Increasing dose Clinical Effects of Benzodiazepines Anxiolysis (relief from anxiety) First effect at low dose High anxiety requires higher dose Sedation Decreased response to constant stimulus Clinical Effects of Benzodiazepines Anticonvulsion (Prevent epileptic fits) Benzodiazepines terminate or prevent fits Emergency drug for epilepsy Amnesia IV give anterograde amnesia Most intense for 20-30 minutes Unpredictable 3

Clinical Effects of Benzodiazepines Effect on Pain experience BZD are NOT analgesic Respond to pain/stimulus Patients may move more during administration of Local. Benzodiazepine Mechanism of Action Principles. GABA (Gamma-aminobutyric acid) 1.GABA causes sedation to CNS 2.BZD bind to BZD receptors 3.When bound will increase GABA effect. Glycine 1.Glycine causes anxiolysis and muscle relaxation 2.Midazolam (BZD) mimics Glycine At the Synapse 4

Peripheral Benzodiazepine Receptors Found in myocardium, kidney and adrenals Role unknown Maybe implicated in cardiovascular effects Side effects of Benzodiazepines Depression of Respiration (breathing) Central nervous system depression and muscle relaxation Decrease cerebral response to CO 2 (carbon dioxide) Synergistic interaction with opioids Enhanced in patients with chronic bronchitis 5

Side effects of Benzodiazepines Cardiovascular effects Reduce blood pressure by decrease in vascular resistance Heart rate increases via baroreceptor reflex Cardiac output uneffected Side effects of Benzodiazepines Drug interactions Enhanced respiritory depression with CNS depressants Synergistic reaction with opioids Pharmacokinetic interactions Eg ketoconazole or erythromycin and midazolam St johns wart and grapefruit juice Side effects of Benzodiazepines Sexual fantasy Reported in both male and female patients Usually patient and dentist opposite sex Dose related (midazolam >0.1mg/kg) 6

Unwanted effects of benzodiazepines Tolerance Patients taking oral BZDs become tolerant to some effects Dependence Long term oral administration will cause addiction and will experience withdrawal reactions if cease Dependence can be activated by acute administration Acute withdrawl can be caused by BZD antagonist Midazolam Water soluble Water soluble ph <4.0 Lipid soluble at physiological ph Lipid soluble means it can cross blood brain barrier No rebound sedation Midazolam or 5mg/5ml 7

Midazolam Metabolised Liver Significant extra hepatic metabolism Less effected by liver disease In acute administration pharmacokinetics not effected by renal (kidney) disease Formulation 10mg 20mg tablets 10mg/5ml solution Dose 10mg to 40mg 60min prior to surgery Elimination half life 20 hours Temazepam Flumazenil - Anexate Reversal agent Antagonist IV injection 500microgram/ml 5ml ampoule High receptor affinity Low intrinsic action 8

Flumazenil - Anexate Mode of action Competitively displaces active benzodiazepine from receptor site. Elimination half life 53 minutes Uses of Flumazenil Not used as a routine Essential emergency drug Should present but not used Residual Sedation after Flumazenil Sedation When flumazenil runs out the patient is still sedated Time 9

Residual Sedation after Flumazenil Due to the different half life's flumazenil is metabolised before midazolam has been made inactive Contraindications to flumazenil Suspected allergy to benzodiazepines Never use for anaphylaxis Patients taking benzodiazepines to treat epilepsy Patient dependent on BZDs 10